Andrew C. Orth Krystal Biotech, Inc. (KRYS) insider trading activity

KRYS Quotes by TradingView

Andrew C. Orth is Chief Commercial Officer of Krystal Biotech, Inc.. Currently has a direct ownership of 100 shares of KRYS, which is worth approximately $15,852. The most recent transaction as insider was on Jun 09, 2023, when has been sold 12,500 shares (Common Stock) at a price of $128.91 per share, resulting in proceeds of $1,611,375. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 100
0% 3M change
0% 12M change
Total Value Held $15,852

ANDREW C. ORTH Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 09 2023
SELL
Open market or private sale
$1,611,375 $128.91 p/Share
12,500 Reduced 99.21%
100 Common Stock
Jun 09 2023
BUY
Exercise of conversion of derivative security
$794,375 $63.55 p/Share
12,500 Added 49.8%
12,600 Common Stock
ACO

Andrew C. Orth

Chief Commercial Officer
Pittsburgh, PA

Track Institutional and Insider Activities on KRYS

Follow Krystal Biotech, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KRYS shares.

Notify only if

Insider Trading

Get notified when an Krystal Biotech, Inc. insider buys or sells KRYS shares.

Notify only if

News

Receive news related to Krystal Biotech, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KRYS